Jagsonpal Pharmaceuticals share price
You have to be logged in to add this to Watchlist.Jagsonpal Pharmaceuticals is trading 5.53% upper at Rs 675.60 as compared to its last closing price. Jagsonpal Pharmaceuticals has been trading in the price range of 686.80 & 643.30. Jagsonpal Pharmaceuticals has given 63.98% in this year & 19.87% in the last 5 days.
Jagsonpal Pharmaceuticals has TTM P/E ratio 46.06 as compared to the sector P/E of 33.29.
The company posted a net profit of 11.46 Crores in its last quarter.
Listed peers of Jagsonpal Pharmaceuticals include Unichem Laboratories (-0.60%), Themis Medicare (2.45%), Jagsonpal Pharmaceuticals (5.53%) etc.
Jagsonpal Pharmaceuticals has a 32.03% public holding.The Mutual Fund holding in Jagsonpal Pharmaceuticals was at 0.11% in 30 Sep 2024. The MF holding has - from the last quarter. The FII holding in Jagsonpal Pharmaceuticals was at 2.30% in 30 Sep 2024. The FII holding has increased from the last quarter.
Jagsonpal Pharmaceuticals share price range
|
| ||||
|
| ||||
Jagsonpal Pharmaceuticals share Key Metrics
| Market Cap ( ₹ Cr.) | 1,690.86 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Jagsonpal Pharmaceuticals Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 23-Oct-24 | Quarterly Results & Stock Split |
| 07-Aug-24 | Quarterly Results |
| 20-May-24 | Audited Results & Final Dividend |
| 02-Feb-24 | Quarterly Results |
| 03-Nov-23 | Quarterly Results |
| 02-Aug-23 | Quarterly Results |
| 23-May-23 | Audited Results & Dividend |
| 08-Feb-23 | Quarterly Results |
| 09-Nov-22 | Quarterly Results |
| 09-Aug-22 | Quarterly Results |
| Meeting Date | Announcement On | Purpose |
| 31-Aug-23 | 02-Aug-23 | AGM |
| 14-Sep-22 | 09-Aug-22 | AGM |
| 17-Jun-22 | 20-May-22 | EGM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 21-May-24 | 06-Sep-24 | 06-Sep-24 | 5 |
| 23-May-23 | 21-Aug-23 | 21-Aug-23 | 5 |
| 19-Oct-21 | 01-Nov-21 | 29-Oct-21 | 4 |
| 30-Jun-21 | - | 22-Sep-21 | 1 |
FAQs about Jagsonpal Pharmaceuticals share price
Jagsonpal Pharmaceuticals is trading at 675.60 as on Mon Nov 25 2024 10:11:47. This is 5.53% upper as compared to its previous closing price of 640.20.
The market capitalization of Jagsonpal Pharmaceuticals is 1690.86 Cr as on Mon Nov 25 2024 10:11:47.
The 52 wk high for Jagsonpal Pharmaceuticals is 654.95 whereas the 52 wk low is 270.05
Jagsonpal Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 46.06
- Sector P/E: 33.29
- Dividend Yield: 0.78%
- D/E ratio: 0.05
Jagsonpal Pharmaceuticals reported a net profit of 22.46 Cr in 2024.
Jagsonpal Pharmaceuticals Quick Links
Jagsonpal Pharmaceuticals Dividend Jagsonpal Pharmaceuticals Bonus Jagsonpal Pharmaceuticals News Jagsonpal Pharmaceuticals AGM Jagsonpal Pharmaceuticals Rights Jagsonpal Pharmaceuticals Splits Jagsonpal Pharmaceuticals Board Meetings Jagsonpal Pharmaceuticals Key Metrics Jagsonpal Pharmaceuticals Shareholdings Jagsonpal Pharmaceuticals Profit Loss Jagsonpal Pharmaceuticals Balance Sheet Jagsonpal Pharmaceuticals Cashflow Jagsonpal Pharmaceuticals Q1 Results Jagsonpal Pharmaceuticals Q2 Results Jagsonpal Pharmaceuticals Q3 Results Jagsonpal Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks